425 results on '"Sechi, Elia"'
Search Results
102. Inflammatory activity following motor progression due to critical CNS demyelinating lesions
103. Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions
104. Diagnostic features of initial demyelinating events associated with serum MOG-IgG
105. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study
106. Spinal arteriovenous fistula's often misdiagnosed as myelitis; can we stem the flow?
107. Long term outcomes in Myelin Oligodendrocyte Glycoprotein-IgG (MOG-IgG) Associated Disorders (1906)
108. Neurological Complications and Neural Autoantibody Profiles Associated with Immune Checkpoint Inhibitors (4215)
109. AMPAR Autoimmunity: Neurological, Oncological and Serological Accompaniments. (4689)
110. Lesion Evolution on MRI in Myelitis Associated with MS, Aquaporin-4-IgG and Myelin Oligodendrocyte Glycoprotein-IgG (4913)
111. Onset of Progressive Motor Impairment in Patients with Critical CNS Demyelinating Lesions (4405)
112. Serum Neurofilament Light Chain Levels Differentiate Spinal Cord Infarction from Inflammatory Myelitis (2620)
113. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies
114. Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD
115. LGI1 antibody encephalitis: acute treatment comparisons and outcome.
116. Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential
117. Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade.
118. Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder
119. Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases
120. Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential
121. The Frequency of Longitudinally Extensive Transverse Myelitis in Multiple Sclerosis in the Era of Glial Biomarkers; A Population-Based Study (P4.2-055)
122. A Population-Based Study of Idiopathic Transverse Myelitis with Aquaporin-4-IgG and Myelin-Oligodendrocyte-Glycoprotein-IgG Assessment (S11.007)
123. Myelin Oligodendrocyte Glycoprotein Autoantibody Myelitis; Clinical characteristics, MRI clues and discriminators from other demyelinating myelitis etiologies (S21.005)
124. Unilateral Motor Progression in Multiple Sclerosis: Association with a Single Critical Corticospinal Tract Lesion (P5.2-012)
125. Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders
126. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody
127. Area postrema syndrome in autoimmune GFAP astrocytopathy
128. Inflammatory activity following motor progression due to critical CNS demyelinating lesions.
129. Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions.
130. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study.
131. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS.
132. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies.
133. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis
134. Applying the 2017 McDonald diagnostic criteria for multiple sclerosis
135. Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder
136. Glial Fibrillary Acid Protein Immunoglobulin G (GFAP-IgG) Related Myelitis: Characterization and Comparison with Aquaporin-4-IgG Myelitis (S13.006)
137. Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder
138. Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings
139. Unilateral motor progression in MS: Association with a critical corticospinal tract lesion.
140. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
141. Paradoxical Effect of Levetiracetam in Newly Diagnosed Type II Focal Cortical Dysplasia
142. Neuralgic amyotrophy mimicking Vernet syndrome
143. Cranial Nerve Involvement in Neuralgic Amyotrophy
144. Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings.
145. Exploratory screening for Fabry’s disease in young adults with cerebrovascular disorders in northern Sardinia
146. Teaching Neuro Images : Subacute encephalopathy in a young woman with THTR2 gene mutation
147. Clinicopathologic features of folate-deficiency neuropathyAuthor Response
148. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.
149. Wernicke-Korsakoff Syndrome
150. Restless legs syndrome and cerebrovascular disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.